PIPELINE THERAPEUTICS
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases. The company's therapies leverage the natural repair process in several different nervous system cell types to target diseases such as multiple sclerosis, providing patients with a treatment to repair damage to the nervous system.
PIPELINE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.pipelinetherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1.858.333.5280
Total Funding:
112 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Google Office 365 Mail Google Cloud GoDaddy DNS Ninja Forms
Similar Organizations
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Neurogene
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Vividion Therapeutics
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Current Advisors List
Current Employees Featured
Founder
Investors List
Brace Pharma
Brace Pharma investment in Series C - Pipeline Therapeutics
Versant Ventures
Versant Ventures investment in Series C - Pipeline Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Pipeline Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Pipeline Therapeutics
Hadean Ventures
Hadean Ventures investment in Series C - Pipeline Therapeutics
Red Tree Venture Capital
Red Tree Venture Capital investment in Series C - Pipeline Therapeutics
Sectoral Asset Management
Sectoral Asset Management investment in Series C - Pipeline Therapeutics
Helicase Venture
Helicase Venture investment in Series C - Pipeline Therapeutics
Franklin Templeton
Franklin Templeton investment in Series C - Pipeline Therapeutics
RBV Capital
RBV Capital investment in Series C - Pipeline Therapeutics
Official Site Inspections
http://www.pipelinetherapeutics.com Semrush global rank: 11.01 M Semrush visits lastest month: 175
- Host name: 220.252.71.34.bc.googleusercontent.com
- IP address: 34.71.252.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pipeline Therapeutics"
Pipeline Therapeutics - Crunchbase Company Profile
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.See details»
Pipeline Therapeutics Announces Global License and …
Apr 17, 2023 SAN DIEGO-- (BUSINESS WIRE)--Pipeline Therapeutics, (“Pipeline”), a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it has entered into a global license …See details»
Pipeline Therapeutics Information - RocketReach
Pipeline Therapeutics is a Pharmaceutical Manufacturing, Pharmaceutical, and Health Care company located in San Diego, California with $5.1 million in revenue and 34 employees. Find …See details»
Pipeline Therapeutics Changes Name to Contineum …
SAN DIEGO, December 13, 2023 – Pipeline Therapeutics, Inc. (the Company) announced today that it has changed its name to Contineum Therapeutics, Inc. (Contineum). The Company chose Contineum (pronounced “Con-tin-E-um”) to …See details»
Pipeline Therapeutics | LinkedIn
Pipeline Therapeutics | 1,035 followers on LinkedIn. Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules …See details»
Overview, News & Similar companies - ZoomInfo.com
View Pipeline Therapeutics (www.pipelinetherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
PIPELINE THERAPEUTICS: Revenue, Worth, Valuation
About PIPELINE THERAPEUTICS PIPELINE THERAPEUTICS plays a vital role in the Pharmaceuticals economy by offering efficient, scalable, and impactful services to its clients …See details»
Pipeline Therapeutics - lifesciencehistory.com
Pipeline Therapeutics is repairing axons to restore function in neurological disorders through creating a portfolio of first-in-class therapeutics.See details»
Pipeline Therapeutics Inc - Company Profile and News
May 9, 2017 Company profile page for Pipeline Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Pipeline Therapeutics - VentureRadar
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including …See details»
Pipeline Therapeutics Enters into Global License and …
Apr 17, 2023 Clinical-stage biopharmaceutical company, Pipeline Therapeutics, enters into a global license and development agreement with Janssen Pharmaceutica NV for the investigational compound, PIPE-307 to treat …See details»
Pipeline Therapeutics - Scientific and Clinical Team | The Org
The Scientific and Clinical Team at Pipeline Therapeutics is dedicated to advancing the company's mission of developing first-in-class small molecules for neuroregeneration. This …See details»
Pipeline Therapeutics Announces Global License and Development ...
Apr 17, 2023 Pipeline Therapeutics announced today that it has entered into a global license and development agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen …See details»
Pipeline Therapeutics Completes $30 Million Series B Financing ...
– Proceeds to advance PIPE-505 in hearing loss and additional neuroregenerative programs focused on synaptogenesis, remyelination and axonal repair – SAN DIEGO, Dec. 18, 2019 – …See details»
Pipeline Therapeutics Completes $80 Million Series C Financing
February 11, 2021 08:00 AM Eastern Standard Time SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a biopharmaceutical company focused on the development and …See details»
Pipeline Therapeutics to Participate in Multiple Upcoming Investor ...
Sep 7, 2023 Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the followiSee details»
Pipeline Therapeutics Announces Global License and Development ...
Apr 17, 2023 – License and development agreement with Janssen leverages Pipeline’s expertise in precision neuroregeneration and Janssen’s development experience across …See details»
Pipeline Therapeutics | VentureRadar
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including …See details»
Pipeline Therapeutics Completes $80 Million Series C Financing ...
Feb 11, 2021 Financing to advance two clinical programs and accelerate discovery efforts SAN DIEGO, February 11, 2021 – Pipeline Therapeutics, a biopharmaceutical company focused on …See details»
5 Biotechs Taking the Pipeline-in-a-Product Approach to Drug ...
1 day ago The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can be a goldmine for smaller companies. But it …See details»